Brian O'callaghan - Nov 17, 2021 Form 4 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)

Role: Director
Signature: /s/ Brian Woodard, Attorney-in-Fact
Stock symbol: BOLT
Transactions as of: Nov 17, 2021
Transactions value $: $0
Form type: 4
Date filed: 11/19/2021, 04:28 PM
Previous filing: Aug 6, 2021
Next filing: Mar 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BOLT	Stock Option (Right to Buy)	Award	$0	+27.9K		$0.00	27.9K	Nov 17, 2021	Common Stock	27.9K	$9.01	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to this option shall vest in equal monthly installments, at a rate of 1/36th of the total number of shares on each monthly anniversary of November 17, 2021 (the "Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the three-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer.

Content

The shares subject to this option shall vest in equal monthly installments, at a rate of 1/36th of the total number of shares on each monthly anniversary of November 17, 2021 (the "Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the three-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer.